Trial · NCT07447739
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The rate of successful respiratory weaning | From initiation of treatment until 7 days after treatment completion | * Defined by a 20% reduction from baseline in mean airway pressure or FiO2 if patient remains intubated * or successful extubation and maintenance of extubation for 7 days after betamethasone completion |
| Secondary | The incidence of adverse events | During betamethasone administration period (5 days) | The incidence of hyperglycemia (\>150 mg/dL) during administration period |
| Secondary | The incidence of adverse events | From the time of initiation of betamethasone until the time of NICU discharge or 52 weeks of age, whichever comes first | The incidence of hypertension (requiring medication) anytime during hospitalization |
| Secondary | The incidence of adverse events | During betamethasone administration period and up to 72 hours after completion of betamethasone administration | The incidence of gastrointestinal perforation (during or less than 72 hours after treatment completion) |
| Secondary | The incidence of adverse events | From the time of initiation of betamethasone until the time of NICU discharge or 52 weeks of age, whichever comes first | The incidence of culture-positive infection that requires treatment |
| Secondary | The incidence of mortbidities associated with extreme prematurity | From admission until the time of NICU discharge or 52 weeks of age, whichever comes first | The incidence of * Severe intraventricular hemorrhage * Periventricular leukomalacia * Retinopathy of prematurity * Hemodynamically signifcant patent ductus arteriosus |
| Secondary | Anthropometric measurements | From discharge to 24 months corrected age | weight at the time of discharge (in grams and percentile rank using Fenton growth curve 2013 for gestational age) and at 24 months corrected age (in grams and their corresponding percentile rank for age using CDC growth chart 0-36 months) |
| Secondary | Anthropometric measurements | From discharge to 24 months corrected age | length at the time of discharge (in centimeters and percentile rank using Fenton growth curve 2013 for gestational age) and at 24 months corrected age (in centimeters and their corresponding percentile rank for age using CDC growth chart 0-36 months) |
| Secondary | Anthropometric measurements | From discharge to 24 months corrected age | Head circumference at the time of discharge (in centimeters and percentile rank using Fenton growth curve 2013 for gestational age) and at 24 months corrected age (in centimeters and their corresponding percentile rank for age using CDC growth chart 0-36 months) |
| Secondary | Neurodevelopmental outcomes | at 24 months corrected age | the results of evaluation utilizing the Bayley Scales of Infant Development. The minimum score is 40 and the maximun score is 160, with a higher score represents better outcome. The score of 100 is average, and 15 points represents 1 standard deviation either way. |
| Secondary | Bronchopulmonary dysplasia diagnosis | at 36 weeks corrected age | Using the 2019 Jensen criteria: * Grade 1 - nasal cannula ≤2 L/min * Grade 2 - nasal cannula \>2 L/min or noninvasive positive airway pressure * Grade 3 - invasive mechanical ventilation |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07447739/registered